Across TCGA pan-cancer cohorts, FAM96AP2 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated FAM96AP2 data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher FAM96AP2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FAM96AP2 expression acts as an unfavorable survival marker, although some lineages such as LUSC and SKCM show a favorable association.
KICH, THCA, and LUSC are the cancer types where FAM96AP2 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.